Most not long ago, it has been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to a big range of endogenous opioids. As opposed to most opioid receptors, this receptor https://jeremyd172vnd6.wikimeglio.com/user